Role of chemokine receptor 2 in rheumatoid arthritis: A research update

被引：8

作者：

Chen, Weile ^{[1
]}

Zhu, Xiangling ^{[1
]}

Xu, Zhen ^{[1
]}

Jiang, Haifeng ^{[1
]}

Wu, Xuming ^{[1
]}

Hong, Wenming ^{[2
]}

Wang, Xinming ^{[2
]}

Tu, Jiajie ^{[1
,3
]}

Wei, Wei ^{[1
,3
]}

机构：

[1] Anhui Med Univ, Inst Clin Pharmacol, Anhui Collaborat Innovat Ctr Antiinflammatory & Im, Key Lab Antiinflammatory & Immune Med,Minist Educ, Hefei, Peoples R China

[2] Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China

[3] 81 Meishan Rd, Hefei, Anhui, Peoples R China

来源：

INTERNATIONAL IMMUNOPHARMACOLOGY | 2023年 / 116卷

基金：

中国国家自然科学基金;

关键词：

CCR2; CCL2; Rheumatoid arthritis; Rheumatoid arthritis -related cells; Therapeutic target; FIBROBLAST-LIKE SYNOVIOCYTES; COLLAGEN-INDUCED ARTHRITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PRO-INFLAMMATORY CYTOKINES; ADJUVANT-INDUCED ARTHRITIS; OXIDATIVE STRESS; DISEASE-ACTIVITY; CCR2; EXPRESSION; CELLS;

D O I：

10.1016/j.intimp.2023.109755

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rheumatoid arthritis (RA) is a multisystemic and inflammatory autoimmune disease characterized by joint destruction. The C-C motif chemokine receptor 2 (CCR2) is mainly expressed in monocytes and T cells, initiating their migration to sites of inflammation, ultimately leading to cartilage damage and bone destruction. CCR2 has long been considered a prospective target for treating autoimmune diseases. However, clinical studies on in-hibitors or neutralizing antibodies against CCR2 in RA have exhibited limited efficacy. Recent evidence indicates that CCR2 may play different roles in RA. Hence, a comprehensive understanding regarding the role of CCR2 may facilitate the development of targeted drugs and provide novel insights for improving CCL2-mediated inflam-matory diseases. This review summarizes the biological characteristics of CCR2, the related signaling pathways, and recent developments in CCR2-targeting therapeutics.

引用

页数：6

共 72 条

[1] Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis [J].

Aeberli, Daniel ;

Kamgang, Richard ;

Balani, Deepak ;

Hofstetter, Willy ;

Villiger, Peter M. ;

Seitz, Michael .

RMD OPEN, 2016, 2 (01)

[2]

Akhter Nadeem, 2019, Cell Physiol Biochem, V53, P1, DOI 10.33594/000000117

[3] Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, 10 IL-10 and MCP-1 in rheumatoid arthritis [J].

An, Qiyuan ;

Yan, Wenkai ;

Zhao, Yi ;

Yu, Keqiang .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 65 :119-128

[4]

Aslani Mona, 2021, Current Drug Discovery Technologies, V18, P65, DOI 10.2174/1570163816666191023103118

[5] Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination [J].

Bauerova, Katarina ;

Acquaviva, Alessandra ;

Ponist, Silvester ;

Gardi, Concetta ;

Vecchio, Daniela ;

Drafi, Frantisek ;

Arezzini, Beatrice ;

Bezakova, Lydia ;

Kuncirova, Viera ;

Mihalova, Danica ;

Nosal, Radomir .

AUTOIMMUNITY, 2015, 48 (01) :46-56

[6] The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis [J].

Boyle, D. L. ;

Soma, K. ;

Hodge, J. ;

Kavanaugh, A. ;

Mandel, D. ;

Mease, P. ;

Shurmur, R. ;

Singhal, A. K. ;

Wei, N. ;

Rosengren, S. ;

Kaplan, I. ;

Krishnaswami, S. ;

Luo, Z. ;

Bradley, J. ;

Firestein, G. S. .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) :1311-1316

[7] Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344 [J].

Brodmerkel, CM ;

Huber, R ;

Covington, M ;

Diamond, S ;

Hall, L ;

Collins, R ;

Leffet, L ;

Gallagher, K ;

Feldman, P ;

Collier, P ;

Stow, M ;

Gu, XM ;

Baribaud, F ;

Shin, N ;

Thomas, B ;

Burn, T ;

Hollis, G ;

Yeleswaram, S ;

Solomon, K ;

Friedman, S ;

Wang, AL ;

Xue, CB ;

Newton, RC ;

Scherle, P ;

Vaddi, K .

JOURNAL OF IMMUNOLOGY, 2005, 175 (08) :5370-5378

[8] Dual role of CCR2 during initiation and progression of collagen-induced arthritis:: Evidence for regulatory activity of CCR2+ T cells [J].

Brühl, H ;

Cihak, J ;

Schneider, MA ;

Plachy, J ;

Rupp, T ;

Wenzel, I ;

Shakarami, M ;

Milz, S ;

Ellwart, JW ;

Stangassinger, M ;

Schlöndorff, D ;

Mack, M .

JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :890-898

[9] Novel treatment strategies in rheumatoid arthritis [J].

Burmester, Gerd R. ;

Pope, Janet E. .

LANCET, 2017, 389 (10086) :2338-2348

[10] Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation. [J].

Caso, Francesco ;

Saviano, Anella ;

Tasso, Marco ;

Raucci, Federica ;

Marigliano, Noemi ;

Passavanti, Saverio ;

Frallonardo, Paola ;

Ramonda, Roberta ;

Brancaleone, Vincenzo ;

Bucci, Mariarosaria ;

Scarpa, Raffaele ;

Costa, Luisa ;

Maione, Francesco .

AUTOIMMUNITY REVIEWS, 2022, 21 (12)

← 1 2 3 4 5 6 7 8 →